Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet

SUMMARY: Dosing regimens of oral bisphosphonates are inconvenient and contribute to poor compliance. The bone mineral density response to a once weekly delayed-release formulation of risedronate given before or following breakfast was non-inferior to traditional immediate-release risedronate given d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: McClung, M. R., Miller, P. D., Brown, J. P., Zanchetta, J., Bolognese, M. A., Benhamou, C. L., Balske, A., Burgio, D. E., Sarley, J., McCullough, L. K., Recker, R. R.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3249191/
https://ncbi.nlm.nih.gov/pubmed/21947137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-011-1791-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados